Roda Vivatex Tbk PT
IDX:RDTX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13 745.6545
15 600
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Roda Vivatex Tbk PT
Current Assets | 815.7B |
Cash & Short-Term Investments | 778.7B |
Receivables | 8.9B |
Other Current Assets | 28.1B |
Non-Current Assets | 2.6T |
Long-Term Investments | 2.5T |
PP&E | 10.4B |
Other Non-Current Assets | 4.4B |
Current Liabilities | 251B |
Accounts Payable | 1.4B |
Accrued Liabilities | 5.7B |
Other Current Liabilities | 243.9B |
Non-Current Liabilities | 130.6B |
Other Non-Current Liabilities | 130.6B |
Balance Sheet
Roda Vivatex Tbk PT
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
84 892
|
298 960
|
459 932
|
496 201
|
486 115
|
202 593
|
177 001
|
159 366
|
341 705
|
578 992
|
|
Cash |
28 138
|
28 072
|
23 178
|
26 203
|
18 910
|
23 590
|
0
|
0
|
0
|
66 257
|
|
Cash Equivalents |
56 754
|
270 888
|
436 754
|
469 998
|
467 205
|
179 003
|
177 001
|
159 366
|
341 705
|
512 735
|
|
Short-Term Investments |
18
|
12 521
|
13 004
|
7 583
|
12 819
|
10 747
|
24 632
|
214 823
|
221 306
|
164 999
|
|
Total Receivables |
72 163
|
56 642
|
52 854
|
12 638
|
11 402
|
8 952
|
29 000
|
36 518
|
35 522
|
48 098
|
|
Accounts Receivables |
70 093
|
53 823
|
48 661
|
9 814
|
9 539
|
8 340
|
21 418
|
35 606
|
34 393
|
45 719
|
|
Other Receivables |
2 070
|
2 818
|
4 193
|
2 823
|
1 863
|
612
|
7 582
|
912
|
1 129
|
2 379
|
|
Inventory |
2 155
|
516
|
1 191
|
1 348
|
1 570
|
1 073
|
1 290
|
1 656
|
2 173
|
2 441
|
|
Other Current Assets |
24 654
|
24 425
|
41 239
|
33 501
|
30 738
|
70 981
|
61 426
|
29 945
|
25 452
|
21 525
|
|
Total Current Assets |
183 882
|
393 063
|
568 221
|
551 269
|
542 644
|
294 345
|
307 484
|
464 028
|
698 377
|
816 054
|
|
PP&E Net |
1 299 035
|
1 318 805
|
14 488
|
15 742
|
15 751
|
16 033
|
13 901
|
11 591
|
31 069
|
19 874
|
|
PP&E Gross |
1 299 035
|
1 318 805
|
14 488
|
15 742
|
15 751
|
16 033
|
13 901
|
11 591
|
31 069
|
19 874
|
|
Accumulated Depreciation |
267 947
|
302 977
|
24 702
|
26 122
|
27 013
|
23 240
|
26 982
|
27 532
|
31 530
|
41 396
|
|
Long-Term Investments |
158 009
|
157 254
|
1 516 138
|
1 710 870
|
1 960 664
|
2 483 483
|
2 246 909
|
2 664 008
|
2 655 566
|
2 600 430
|
|
Other Long-Term Assets |
2 461
|
3 037
|
2 908
|
2 580
|
7 431
|
1 928
|
402 768
|
21 479
|
2 310
|
3 975
|
|
Total Assets |
1 643 386
N/A
|
1 872 159
+14%
|
2 101 754
+12%
|
2 280 462
+9%
|
2 526 490
+11%
|
2 795 788
+11%
|
2 971 062
+6%
|
3 161 105
+6%
|
3 387 321
+7%
|
3 440 333
+2%
|
|
Liabilities | |||||||||||
Accounts Payable |
5 437
|
4 908
|
4 849
|
5 908
|
4 455
|
2 568
|
3 274
|
21 946
|
11 098
|
5 685
|
|
Accrued Liabilities |
5 005
|
5 446
|
4 523
|
5 628
|
4 441
|
5 058
|
3 888
|
4 096
|
3 900
|
5 881
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
758
|
2 024
|
137
|
145
|
478
|
72
|
173
|
188
|
|
Other Current Liabilities |
193 158
|
180 327
|
164 565
|
105 845
|
111 689
|
133 233
|
104 302
|
120 851
|
250 124
|
385 245
|
|
Total Current Liabilities |
203 601
|
190 681
|
174 694
|
119 405
|
120 722
|
141 004
|
111 942
|
146 966
|
265 295
|
396 998
|
|
Long-Term Debt |
0
|
0
|
540
|
0
|
0
|
65
|
72
|
0
|
188
|
0
|
|
Other Liabilities |
88 096
|
91 913
|
98 057
|
106 095
|
92 345
|
130 015
|
122 396
|
109 468
|
149 307
|
158 138
|
|
Total Liabilities |
291 697
N/A
|
282 594
-3%
|
273 291
-3%
|
225 500
-17%
|
213 067
-6%
|
271 084
+27%
|
234 410
-14%
|
256 434
+9%
|
414 790
+62%
|
555 136
+34%
|
|
Equity | |||||||||||
Common Stock |
134 400
|
134 400
|
134 400
|
134 400
|
134 400
|
134 400
|
134 400
|
134 400
|
134 400
|
134 400
|
|
Retained Earnings |
1 212 285
|
1 449 396
|
1 688 722
|
1 911 914
|
2 169 035
|
2 379 105
|
2 590 931
|
2 756 837
|
2 826 937
|
2 735 448
|
|
Additional Paid In Capital |
9 414
|
9 414
|
9 449
|
10 351
|
11 225
|
11 225
|
11 225
|
11 225
|
11 225
|
11 225
|
|
Unrealized Security Profit/Loss |
280
|
484
|
21
|
884
|
1 236
|
25
|
0
|
0
|
0
|
0
|
|
Treasury Stock |
4 129
|
4 129
|
4 129
|
2 587
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
96
|
2 210
|
30
|
4 124
|
|
Total Equity |
1 351 690
N/A
|
1 589 565
+18%
|
1 828 463
+15%
|
2 054 962
+12%
|
2 313 423
+13%
|
2 524 705
+9%
|
2 736 652
+8%
|
2 904 671
+6%
|
2 972 531
+2%
|
2 885 197
-3%
|
|
Total Liabilities & Equity |
1 643 386
N/A
|
1 872 159
+14%
|
2 101 754
+12%
|
2 280 462
+9%
|
2 526 490
+11%
|
2 795 788
+11%
|
2 971 062
+6%
|
3 161 105
+6%
|
3 387 321
+7%
|
3 440 333
+2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
268
|
268
|
268
|
268
|
269
|
269
|
269
|
269
|
269
|
269
|